Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Real World Evidence Solutions Market, by Component
1.4.2 North America Real World Evidence Solutions Market, by Therapeutic Area
1.4.3 North America Real World Evidence Solutions Market, by End-user
1.4.4 North America Real World Evidence Solutions Market, by Application
1.4.5 North America Real World Evidence Solutions Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Scenario and Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Real World Evidence Solutions Market
Chapter 4. North America Real World Evidence Solutions Market by Component
4.1 North America Services Market by Country
4.2 North America Data Set Market by Country
Chapter 5. North America Real World Evidence Solutions Market by Therapeutic Area
5.1 North America Oncology Market by Country
5.2 North America Cardiology Market by Country
5.3 North America Neurology Market by Country
5.4 North America Diabetes Market by Country
5.5 North America Respiratory Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Real World Evidence Solutions Market by End-user
6.1 North America Healthcare Companies Market by Country
6.2 North America Healthcare Payers Market by Country
6.3 North America Healthcare Providers Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Real World Evidence Solutions Market by Application
7.1 North America Drug Development & Approvals Market by Country
7.2 North America Medical Device Development & Approvals Market by Country
7.3 North America Reimbursement/Coverage & Regulatory Decision Making Market by Country
7.4 North America Post Market Safety & Adverse Events Monitoring Market by Country
Chapter 8. North America Real World Evidence Solutions Market by Country
8.1 US Real World Evidence Solutions Market
8.1.1 US Real World Evidence Solutions Market by Component
8.1.2 US Real World Evidence Solutions Market by Therapeutic Area
8.1.3 US Real World Evidence Solutions Market by End-user
8.1.4 US Real World Evidence Solutions Market by Application
8.2 Canada Real World Evidence Solutions Market
8.2.1 Canada Real World Evidence Solutions Market by Component
8.2.2 Canada Real World Evidence Solutions Market by Therapeutic Area
8.2.3 Canada Real World Evidence Solutions Market by End-user
8.2.4 Canada Real World Evidence Solutions Market by Application
8.3 Mexico Real World Evidence Solutions Market
8.3.1 Mexico Real World Evidence Solutions Market by Component
8.3.2 Mexico Real World Evidence Solutions Market by Therapeutic Area
8.3.3 Mexico Real World Evidence Solutions Market by End-user
8.3.4 Mexico Real World Evidence Solutions Market by Application
8.4 Rest of North America Real World Evidence Solutions Market
8.4.1 Rest of North America Real World Evidence Solutions Market by Component
8.4.2 Rest of North America Real World Evidence Solutions Market by Therapeutic Area
8.4.3 Rest of North America Real World Evidence Solutions Market by End-user
8.4.4 Rest of North America Real World Evidence Solutions Market by Application
Chapter 9. Company Profiles
9.1 IBM Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional & Segmental Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Oracle Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 PPD, Inc. (Thermo Fisher Scientific, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 UnitedHealth Group, Inc. (Optum, Inc.)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental Analysis
9.5 Syneos Health, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Acquisition and Mergers:
9.6 IQVIA Holdings, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Partnerships, Collaborations, and Agreements:
9.6.4.2 Acquisition and Mergers:
9.7 Medpace Holdings, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.8 ICON plc
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Acquisition and Mergers:
9.9 PerkinElmer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Product Launches and Product Expansions:
9.10. Parexel International Corporation (Phoenix Parentco, Inc.)
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 